EML4-ALK AND ITS INHIBITORS: A NEW PARADIGM IN CANCER TREATMENT

被引：0
|
作者：
Mano, H. [1 ,2 ]
机构：
[1] Jichi Med Univ, Div Funct Genom, Shimotsuke, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo 1138654, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [1] EML4-ALK: Update on ALK Inhibitors
    Bearz, Alessandra
    Bertoli, Elisa
    Stanzione, Brigida
    De Carlo, Elisa
    Del Conte, Alessandro
    Bortolot, Martina
    Torresan, Sara
    Berto, Eleonora
    Da Ros, Valentina
    Pelin, Giulia Maria
    Fassetta, Kelly
    Rossetto, Silvia
    Spina, Michele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
  • [2] EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
    Choi, Young Lim
    Soda, Manabu
    Yamashita, Yoshihiro
    Ueno, Toshihide
    Takashima, Junpei
    Nakajima, Takahiro
    Yatabe, Yasushi
    Takeuchi, Kengo
    Hamada, Toru
    Haruta, Hidenori
    Ishikawa, Yuichi
    Kimura, Hideki
    Mitsudomi, Tetsuya
    Tanio, Yoshiro
    Mano, Hiroyuki
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18): : 1734 - 1739
  • [3] EML4-ALK
    Solomon, B.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S18 - S18
  • [4] TREATMENT OF EML4-ALK REARRANGED NSCLC
    Jaenne, P. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 79 - 79
  • [5] Endometrial cancer with an EML4-ALK rearrangement
    Craig, Jeffrey W.
    Quade, Bradley J.
    Muto, Michael G.
    MacConaill, Laura E.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2018, 4 (04):
  • [6] The Change in Paradigm for NSCLC Patients with EML4-ALK Translocation
    Bearz, Alessandra
    De Carlo, Elisa
    Del Conte, Alessandro
    Spina, Michele
    Da Ros, Valentina
    Bertoli, Elisa
    Revelant, Alberto
    Stanzione, Brigida
    Tirelli, Umberto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [7] Atypical Lung Carcinoids with EML4-ALK Fusion and Responses to ALK Inhibitors
    Waliany, Sarah
    Hung, Yin P.
    Abu Rous, Fawzi
    Do, Andrew
    Peterson, Jennifer
    Meservey, Caitlin
    Digumarthy, Subba R.
    Gadgeel, Shirish M.
    Lin, Jessica J.
    Meadori, Catherine B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E32 - E33
  • [8] Carcinoma of Unknown Primary with EML4-ALK Fusion Response to ALK Inhibitors
    Zhao, Peng
    Peng, Ling
    Wu, Wei
    Zheng, Yi
    Jiang, Weiqin
    Zhang, Hangyu
    Tong, Zhou
    Liu, Lulu
    Ma, Ruobing
    Wang, Liping
    Yao, Ming
    Wang, Kai
    Fang, Weijia
    Wu, Liming
    ONCOLOGIST, 2019, 24 (04): : 449 - 454
  • [9] Different response to ALK inhibitors in EML4-ALK positive mediastinal cancer of unknown primary.
    Hu, Chunhong
    Zhao, Lishu
    Wu, Fang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Transcriptomic overview of EML4-ALK lung cancer cells resistant to ALK inhibitors highlights a vulnerability to CDK inhibitors
    Paliouras, Athanasios R.
    Magee, Peter
    Sahoo, Sudhakar
    Leong, Hui Sun
    Krebs, Matthew
    Blackhall, Fiona
    Lovly, Christine M.
    Garofalo, Michela
    CANCER RESEARCH, 2019, 79 (13)
12345